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Abstract 
 This paper is the third in a series of reviews of cross-cultural studies of symptoms at 
midlife.  The goal of this review is to examine methods used previously in cross-cultural studies 
of menopause and women’s health at midlife to (1) identify challenges in the measurement of 
somatic symptoms across cultures and (2) recommend questions and tools that can be used in 
future research.  This review also aims to examine the determinants of somatic symptoms.  
The review concludes that methods used for assessing somatic symptoms differ across 
studies.  Somatic symptoms, particularly, aches, pain, and fatigue have a high prevalence.  
Statistically significant differences were seen in the prevalence of somatic symptoms across 
cultures.  Based on the number of studies that demonstrated cross-cultural differences in 
symptom prevalence, we recommend that the following symptoms be included in future studies 
of symptoms at midlife: headaches, aches/pain, palpitations, dizziness, fatigue, breathing 
difficulties, numbness or tingling, and gastrointestinal difficulties.  We also recommend that 
objective measures of physical function be administered when possible to supplement subjective 
self-evaluation. 
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1. Introduction 
 This is the third in a series of reviews of cross-cultural studies of menopausal symptoms.  
The purpose of this review is to examine methods used in cross-cultural comparisons of somatic 
symptoms among women at midlife and to examine the determinants of somatic complaints.  
The goal of this review is to make recommendations that will improve cross-cultural 
comparisons in the future. 
 Midlife is characterized by an increasing prevalence of somatic symptoms [1,2]; 
however, the frequencies of these symptoms vary across cultures [3-5], suggesting an influence 
of lifestyle and/or sociocultural expectations on symptom experience and report.  Somatic 
symptoms is a broad category of complaints that can include headaches, low back pain, neck 
pain and stiffness, joint pain and stiffness, numbness, shortness of  breath, and dizziness. 
Somatic symptoms can be described as any symptom or complaint that interferes with physical 
function [6].   
 These pain and non-pain symptoms may have physiological causation and/or may be 
associated with depression or anxiety [6-8].  For example, in a longitudinal study of aches and 
4 
 
joint pain in Melbourne, Australia, X-ray analyses confirmed the presence of osteoarthritis in 
some, but not all, of the women with joint pain.  The risk for aches and joint stiffness increased 
with postmenopausal status, a higher body mass index (BMI), unemployment, and depressed 
mood [9].   
 Pain is a complex construct; therefore it may not be reflected in a single measure [10].  
This is probably true for non-pain-related somatic symptoms as well.  The following review 
considers how somatic symptoms have been assessed in cross-cultural surveys.  Symptom 
determinants are also examined as part of our goal to improve future cross-cultural comparisons 
[11].  The review concludes with recommendations. 
 
2. Methods 
 This review is limited to studies that compare somatic symptom frequencies across ethnic 
groups within or between countries.  The studies themselves are described in more detail in the 
overview to this series of review papers [11].  
 Frequencies of somatic symptoms were compared to the extent possible.  We reviewed 
the disparate lists of somatic symptoms published across the studies.  The most frequently 
queried symptoms were collapsed into broader categories for comparisons.  Determinants of 
somatic symptoms were then compared to the extent possible, limited by the different variables 
entered into multivariate analyses.  Finally, this review ends with recommendations made to 
facilitate future cross-cultural research. 
 
3. Results 
3.1. Measures of symptom frequencies 
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 Eight symptom checklists and scales, in various combinations, were used as the bases for 
the eight studies profiled here.  Table 1 provides the full name for each study, and the overview 
[11] describes each study in more detail. 
[Table 1 goes about here.] 
 The Greene Climacteric Scale [12] was used in the AJMWHS [13].  In addition to 
individual symptom reports, a somatic factor score was computed from the Greene Climacteric 
Scale.  Table 1 shows the 9 somatic symptoms queried in the AJMWHS, and Table 2 includes 7 
of these symptoms for comparison across cultures.  Australian women were more likely to report 
muscle or joint pains, but Japanese women were more likely to report palpitations and dizziness.  
Somatic factor scores computed from the Greene Climacteric Scale did not differ between 
Australian (3.47) and Japanese (3.56) participants. 
[Tables 2 goes about here.] 
 In addition to the symptom checklist, the SF-36 scale was used to provide composite 
scores for physical health [14].  Profiles generated by the SF-36 relevant to somatic symptoms 
include physical functioning (general activity level, ability to climb stairs, to walk different 
distances, and to carry out activities of daily living), physical role limitations, bodily pain, and 
general health.  After controlling for confounding variables, Japanese women reported 
significantly higher scores in physical function, but Australian women scored significantly 
higher on vitality and general health.   
 The Everyday Complaint List [15,16] was the base for symptom lists used in DAMeS [4], 
HWHS [2,17], and SWAN [18].  The core list of 16 symptoms, first used in Massachusetts [19], 
Canada [20], and Japan [21], included headaches, backaches, and aches/stiffness in joints 
experienced over the past two weeks [15].   
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 A list of 25 symptoms based on the Everyday Complaint List was used in DAMeS. Eight 
of the 10 somatic symptoms are shown in Table 2 where percentages reflect the number of 
women who said they had experienced the symptom, regardless of frequency.  Women in Beirut 
were significantly more likely to report palpitations, breathing difficulties, gastrointestinal 
complaints and numbness, but significantly less likely to report joint aches/stiffness compared 
with women in other study sites [4]. 
 The Everyday Complaint List was modified for use in the HWHS following the piloting 
of the survey to women of European, Japanese, Chinese, and mixed ancestry [2].  Participants 
were presented with a list of 30 symptoms.  Table 1 shows the somatic symptoms, and Table 2 
compares results between European- and Japanese-American women for 4 of the 6 symptoms.  
European-Americans were significantly more likely to report dizziness and fatigue compared to 
Japanese-Americans [17].   
 The Everyday Complaint List was also the base for the 10 item symptom list used in 
SWAN [18].  Three somatic symptoms are included in Table 2.  Gold et al. [22] examined 
“stiff/sore” in a multivariate analysis to demonstrate that African American and Hispanic women 
were less likely to complain of feeling stiffness or soreness in joints, neck or shoulders compared 
to European-American women.  Hispanic women were more likely to complain of heart 
pounding.  The SF-36 was also used in SWAN [23].  Results were compared for bodily pain, 
role-physical, and vitality, with Hispanics most likely to report all three categories of impairment 
in quality of life.  This remained true for bodily pain after controlling for covariates in 
sociodemographic, health, lifestyle, and social circumstances models.   
 The Midlife Women’s Symptom Index [24] was used in the FMEG [25] to query the 
presence of 73 symptoms, at least 22 of which could be classified as somatic symptoms.  Of 
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these, seven are included in Tables 1 and 2 for comparison purposes.  European-American 
women reported the highest frequency of every symptom listed in Table 2 with the exception of 
numbness and tingling which was most frequently reported by African-American women.    
 The Kupperman Menopausal Index was used to develop a Menopause Symptom List 
(MSL) administered in the POAS [26].  The most prevalent symptom in the past month was 
“aches, joint pain, and stiffness,” reported by 75% of women during the late transition stage [27].  
The prevalence of aches is shown in a bar graph in relation to menopausal stage, but not in 
relation to race/ethnicity, therefore somatic symptom frequencies could not included be in Table 
2.   
 In addition to the MSL, a Daily Symptom Rating (DSR) form included the following 
somatic symptoms:  fatigue or lack of energy; headache; aches, joint pain, stiffness; insomnia; 
dizziness; poor coordination; breast tenderness; swelling, bloating, weight gain.  The DSR was 
completed each day for one menstrual cycle.  DSR scores were calculated by summing item 
ratings for follicular days (6–12) and late luteal days (23–28) [28].  Factor analyses were used to 
group swelling and weight gain, appetite changes, breast tenderness, aches, and headaches into 
Factor 2 (somatic symptoms).  In addition, the SF-12 Health Survey was used to evaluate 
physical health.  African American women reported higher Factor 2 somatic scores (31.0 vs. 
29.0), and lower SF-12 (physical health) scores (48.4 vs. 52.4) [28]. 
 The WHiMNS compared 16 symptoms across three groups of women living in Israel 
[29].  Ten somatic symptoms are shown in Table 1, of which 6 are included in Table 2 for 
comparison.  Soviet immigrants to Israel reported the highest frequency of fatigue and breathing 
difficulties.  Arab Israelis reported the highest frequency of headaches. 
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 The WISHeS study used the Menopause-Specific Quality of Life Questionnaire [3].  This 
self-administered instrument queried symptom experience in the previous month and the degree 
to which the symptoms were bothersome on a 7-point Likert scale. Symptoms scored 3 or higher 
were categorized as clinically meaningful.  See Table 1 for the 13 somatic items included in the 
symptom list, of which 4 were included in Table 2 for cross-cultural comparisons.  Women in the 
U.S. and U.K reported a higher prevalence of aches/pain and fatigue compared to women in 
France, Italy, and Germany. 
 
3.2 Symptom lists and cross-cultural comparisons 
 Table 2 illustrates the ubiquity of somatic symptoms at midlife.  Many of the somatic 
symptoms queried by individual surveys (Table 1) are not included in Table 2 because of limited 
comparability across studies; therefore somatic symptoms are even more common and varied 
than reflected in Table 2.  Furthermore, fatigue and muscle/joint pain were the most frequently 
reported symptoms, not just among somatic symptoms, but even compared to vasomotor 
symptoms in the AJMWHS [13] and WISHeS [3].  The symptoms most likely to be reported as 
bothersome in the whole sample of WHiMNS were back/neck aches (63%) and headaches 
(48%).  These frequencies exceeded the frequency for hot flashes (34%) [29].  In the HWHS the 
most often reported symptoms were aches and stiffness in joints (64%), backaches (51%), and 
lack of energy (48%).  These also exceeded the frequencies reported for hot flashes (34%) [17].   
 The high rate of somatic symptoms across studies supports the need to include somatic 
symptoms in studies of midlife health.  “Headaches” were queried by all studies, including 
POAS [30], although WISHES included headache with neck and shoulder aches.  All studies 
also queried aches and pain (i.e., soreness or stiffness in muscles, joints, legs, neck and/or 
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shoulders).  Six of the studies shown in Table 2 asked about fatigue.  Less commonly addressed 
were palpitations, dizziness, breathing difficulties, and gastrointestinal complaints, followed by 
numbness or tingling. 
 As illustrated in Table 3, the highest number of significant differences between countries 
or ethnic groups was shown in DAMeS and FMEG.  DAMeS compared women across very 
different countries (Morocco, Lebanon, Spain and the U.S.).  Only the AJMWHS approached 
that degree of disparity in cross-country comparison.  Although WiSHES compared the U.S. 
with European countries, the cross-country differences are probably not as great as across the 
DAMeS sites.  FMEG was the only internet study.  Another intra-U.S. study, HWHS, found 
fewer significant differences across ethnic groups.  WHiMNS, also a comparison of ethnic 
groups within one country (Israel), was more similar in results to the HWHS (face-to-face 
interviews) than to the FMEG (internet survey).   
[Table 3 goes about here] 
3.3  Determinants of somatic symptoms across studies 
 The variables entered into multivariate analyses varied between studies and for different 
variables within studies (i.e., aches, join pain and stiffness [27] and headaches [30]).  In the 
HWHS, multivariate analyses have not been carried out for somatic symptoms [17].  The study 
of FMEG examined variation in the total number of symptoms, but not individual somatic 
symptoms [25].  In SWAN, factor analysis was used to cluster headaches with feeling tense, blue 
or depressed, irritable, and forgetfulness [18].  Although the cluster is of interest, it is impossible 
to know the determinants of headaches alone.  Similarly, in Israel, factor analysis was used by 
WHiMNS investigators to create a general somatic symptoms scale from eye irritation, 
headaches, and dry skin [29].  The determinants for headaches alone cannot be determined.   
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 In DAMeS, multivariate analyses were carried out only for a subset of symptoms, but 
demonstrated that country of residence remained a significant determinant of cardiovascular, 
joint pain, and fatigue symptoms [4].  In POAS [27], African American women were 1.31 times 
more likely to report aches, joint pain, and stiffness compared to white women in the 
multivariate model (95% CI 1.00-1.73).  Ethnicity was not, however, a determinant of headache 
report [30].  WISHES is a wonderful example of examining all symptoms in multivariate models 
and presenting the results for easy comparison across symptoms.  The prevalence of each 
symptom at age 50 is given for each symptom along with the significant determinants [3].   
 Table 4 shows the determinants of various measures of somatic symptom frequencies 
across 6 of the 8 studies reviewed. Looking across the studies, country or ethnicity, age (with the 
exception of DAMeS), and menopausal status were the variables consistently examined and 
consistently found to be significant determinants of somatic symptoms.  BMI was not as 
consistently examined, but appears to be important in explaining the frequency of aches and 
pains. 
[Table 4 goes about here.] 
 
4. Discussion and recommendations 
 The breadth of the category of somatic symptoms resulted in an immediate challenge as 
we divided up symptoms for separate review.  For example, palpitations and shortness of breath 
can interfere with physical function (and thereby meet our criteria for somatic symptoms [6]; 
however, a rapid heartbeat and shortness of breath may also indicate a stress response.  We chose 
to include overlapping symptoms in both the psychological [31] and somatic reviews. 
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 Another challenge is apparent in Table 1 because different words or phrases were used by 
symptom lists to describe similar somatic complaints.  Perhaps it is not surprising that there is 
more variation across studies in the description of somatic symptoms than in descriptions of, for 
example, vasomotor symptoms at midlife.  One hallmark of somatic symptoms is their vague 
character.  Making symptom lists comparable within a cross-cultural study is most important and 
that seems to have been accomplished in each of these studies despite the need to translate 
concepts into other languages and across cultures. 
 For cross-study comparisons, differences in the presentation of results make it difficult to 
look for general trends.  Composite factor scores (as in AMJWHS, POAS, and WHiMNS) are 
made up of different symptoms, therefore are limited in comparability.  Headaches cluster with 
psychological symptoms in one study [18], but with somatic symptoms in another [29].   
 Sample recruitment and method of questionnaire administration affect our ability to 
compare.  For example, in a four continent survey of women aged 40-70 carried out by 
Heinemann et al. [32], women in four European countries and in the U.S. were recruited from 
existing ACCESS panels, while in three Latin America countries and Indonesia, women were 
recruited from house to house interviewers.  The same Menopausal Rating Scale was used to 
evaluate the prevalence and severity of menopausal complaints, but the difference in sample 
recruitment might limit comparability.  In the comparison presented here, the internet survey 
[25] found significant differences across all symptom categories presented in Table 2.  Another 
survey carried out in the U.S. that used face-to-face interviews [17] did not find the same number 
of significant differences.  The internet survey, FMEG, included different ethnic groups in their 
analyses, but there may also have been some methodological bias. 
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 While hot flashes are generally considered the hallmark symptom of menopause, a 
review of the literature shows that somatic symptoms are often more frequent complaints [21, 
32]  The same is true in many, but not all [4], of the studies reviewed here.  Despite their 
frequency, the presence of somatic symptoms is often minimized in studies of symptom 
frequencies at midlife because, for example, joint and muscular discomforts are not viewed as a 
symptom of menopause per se [32, 34]. 
 In addition to the recommendations made in our overview [11], we recommend that, 
whatever the symptom list, headaches be included in a separate category (not combined with 
neck and shoulder aches) and that headaches be investigated in more detail to separate migraines 
from stress headaches [35].  This is because the experience migraines may change with the 
hormonal fluctuations of menopause [36].  Whether viewed as psychological or somatic 
complaints, we recommend that dizziness, chest pain, palpitations, breathing difficulties, and 
numbness be included on all lists.  Although gastrointestinal discomforts was probably first 
included in the Everyday Complaint list [15] as a symptom used to distract attention away from 
the stereotypical menopausal symptoms, differences in the frequency of GI complaints across 
countries [4] and cultures [25] suggest that there is something to be learned about women’s 
health at midlife through the inclusion of gastrointestinal complaints on questionnaires.  As for 
the use of SF-36 and somatic symptom scores, these are valuable as subjective measures of 
function. 
 Objective measures avoid the problem of cultural reporting bias [37, 38] and provide an 
alternative source of information about symptom experience.  A study in Taiwan [39] examined 
menopausal status in relation to flexibility, muscular strength, and balance, and found that 
flexibility did not vary, but peri- and post-menopausal women had weaker grip strengths and 
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compromised balance compared to pre-menopausal women.  The Michigan Bone Health and 
Metabolism study also found reduced hand grip strength among postmenopausal women [40].  In 
contrast, a cohort study in the UK found that among 53-year-old women there was no association 
between menopausal status and balance, and after adjustment for current height, the decreasing 
grip strength from pre- to peri- to post-menopausal categories attenuated, with a small additional 
attenuation after adjustment for current weight and other covariates [41].  We recommend that 
flexibility be assessed by simple stand-and-reach and sit-and-reach tests, muscular strength be 
assessed by grip strength, and balance be assessed by one-legged standing with eyes open or 
closed [39].   
 In conclusion, we show here that methods used for assessing somatic symptoms differ 
across studies, and that these symptoms, particularly, aches, pain, and fatigue, have a high 
prevalence.  The prevalence of somatic symptoms varies among cultures, even after controlling 
for a myriad of relevant factors.  We recommend that the following symptoms be included in 
future studies of symptoms at midlife: headaches, aches/pain, palpitations, dizziness, fatigue, 
breathing difficulties, numbness or tingling, and gastrointestinal difficulties.  We also 
recommend that objective measures be administered when possible to supplement subjective 
self-evaluation of physical function. 
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Table 3:  Significance of country/ethnic differences in relation to somatic symptoms by study  
*p<0.05, **p<0.01 
NS = examined and not significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AJMWHS 
[13,14] 
DAMeS 
[4] 
FMEG 
[25] 
HWHS 
[17] 
SWAN 
[22,23] 
WHiMNS 
[29] 
WISHES 
[3] 
Headaches NS * ** NS NS * NS 
Aches/pain ** * ** NS * NS * 
Palpitations ** ** **  *   
Dizziness ** **  *  NS  
Fatigue NS ** ** **  ** * 
Breathing 
difficulties 
NS ** **   *  
Numbness or 
tingling 
 ** **     
Gastrointestinal  ** **   NS NS 
Somatic factor score  NS       
SF-36 physical 
functioning 
**       
SF-36 general 
health 
**       
SF-36 vitality **    **   
SF-36 bodily pain NS    **   
SF-36 role physical NS    **   
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Table 4:  Factors significant in multivariate models of somatic symptoms 
 AJMWHS 
[13,14] 
DAMeS 
[4] 
POAS 
[27,30] 
SWAN 
[22] 
WHiMNS 
[29] 
WISHES 
[3] 
Country or 
ethnic group 
SF-36a  physical 
function, role 
physical, bodily 
pain, general 
health, vitality 
Joint 
painsc 
Cardio-
vascularc 
Fatiguec 
Aches, joint 
pain, stiffnessd 
Headachee 
Stiff/soref
Heart poundingf 
Somatic 
scaleg 
Fatigueh  
Aching in  muscles 
and jointsh 
Age or 
Age2 
 
SF-36a physical 
function, role 
physical, bodily 
pain, general 
health, vitality 
 Aches, joint 
pain, stiffnessd 
 
Stiff/soref
 
Somatic 
scaleg 
Fatigueh  
Aching in muscles 
and jointsh  
Headachesh 
Menopause 
status or 
Early surgical 
menopause 
Somatic factor 
scoreb 
SF-36 bodily painb 
Joint 
painsc 
Aches, joint 
pain, stiffnessd 
Stiff/soref
Heart poundingf 
Somatic 
scaleg 
Fatigueh 
Headachesh 
BMI   Aches, joint 
pain, stiffnessd 
Stiff/soref  Aching in muscles 
and jointsh 
Smoking 
 
 Fatiguec  Stiff/soref
Heart poundingf 
  
Physical 
activity 
 Fatiguec  Stiff/soref
Heart poundingf 
  
PMS 
 
  Headachee    
Education 
 
   Heart poundingf Somatic 
scaleg 
 
Employment 
status 
SF-36a physical 
function, role 
physical, bodily 
pain, general 
health, vitality 
Fatiguec  NS   
Ability to pay 
for basics 
   Stiff/soref
Heart poundingf 
  
Mental or 
physical 
morbidity 
     Fatigueh 
GI complaintsh 
Achingh 
Headachesh 
Healthy 
lifestyle 
    Somatic 
scaleg 
 
Perceived 
stress 
  Aches, joint 
pain, stiffnessd 
Headachee 
   
Depressive 
symptoms 
  Aches, joint 
pain, stiffnessd 
Headachee 
 Somatic 
scaleg 
 
Estradiol 
variability 
  Aches, joint 
pain, stiffnessd 
   
 
Variables entered into models 
a Age, marital status, education, employment status, income 
b Country of residence and menopause status 
c Country of residence, age, education level, employment status, smoking, exercise, menopausal status. 
d Menopausal status, age, race, history of depression, current smoking, BMI, perceived stress, estradiol variability 
e Menopausal status, PMS, perceived stress, history of depression, smoking, age, race, estradiol level 
f Age, education, employment status, ability to pay for basics, race/ethnicity, marital status, parity, menopausal status, BMI, 
smoking, physical activity 
g Cultural group, age, education, family status (married/other), menopausal status, healthy lifestyle (yes/no) ever use of HRT, 
chronic morbidity, BMI, level of depressive symptoms 
h Age, age2, mental morbidity, physical morbidity, early surgical menopause, BMI, country (UK/US, FR/IT, GE) 
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Table 1:  Measures of somatic symptoms in cross‐cultural studies of women’s health at midlife.  (Symptom classification consistent with Table 2) 
Studies  Instrumen
ts 
Questions  Head 
aches 
Aches/ 
Pains 
Palpi‐
tations 
Dizzi‐
ness 
Fatigue  Breathin
g 
Difficultie
s 
Numbnes
s or 
tingling 
Gastro‐
intestinal 
difficulties 
Other (not in 
Table 2) 
Australian/ 
Japanese 
Midlife 
Women’s 
Health Study 
(AJMWHS) 
[13,14] 
Green 
Climacteric 
Scale 
 
The extent to 
which you are 
bothered at 
the moment 
by the 
following 
symptoms  
Headache  Muscle or 
joint pains 
Heart 
beating 
quickly 
or 
strongly 
Feeling 
dizzy or 
faint 
Feeling 
tired or 
lacking in 
energy 
Breathing 
difficulties 
Part of 
body 
feeling 
numb or 
tingling 
Pressure or 
tiredness in 
head/body; 
Loss of feeling 
in hands or 
feet; 
Decision At 
Menopause 
Study 
(DAMeS) [4] 
 
The 
Everyday 
Complaint 
Checklist 
 
During the 
past month, 
have you 
experienced 
any of the 
following?  
Headaches Joint pains Palpi‐
tations 
Dizziness Fatigue/ 
weakness 
Shortness 
of breath 
Numbness Gastrointestinal 
symptoms 
Chest
pressure/pain; 
Weight gain 
Four Major 
Ethnic 
Groups 
(FMEG) [25]  
 
The Midlife 
Women’s 
Symptom 
Index 
 
Presence and 
severity of 
symptoms 
during the 
past 6 months 
Headache Neck and 
skull 
aches 
Heart 
racing 
Exhaustion 
or fatigue 
Difficulty 
breathing 
Numbness 
or tingling 
Loose bowel 
movement 
Hilo 
Women's 
Health 
Survey 
(HWHS) [17] 
 
The 
Everyday 
Complaint 
List 
 
Over the past 
2 weeks, have 
you ever been 
bothered by 
any of the 
following 
symptoms  
Headaches Aches/stif
fness in 
joints 
Dizzy 
spells 
Lack of 
energy 
Backaches;  
Leg cramps 
Penn 
Ovarian 
Aging Study 
(POAS) [26‐
28,30] 
The 
Kupperman 
Complaint 
Checklist 
Whether each 
symptom 
occurred in 
the past 
month, the 
Headaches Aches, 
joint pain, 
and 
stiffness   
 
21 
 
frequency and 
severity (0‐3) . 
Study of 
Women's 
Health 
Across the 
Nation 
(SWAN) 
[18,22,23]  
The 
Everyday 
Complaint 
Checklist 
(modified 
version) 
How 
frequently 
experienced 
each of 4 
symptoms in 
the previous 2 
weeks. 
Headaches Stiffness 
or 
soreness 
in joints, 
neck or 
shoulders 
Heart 
pounding 
or racing 
 
The 
Women’s 
Health at 
Midlife 
National 
Study 
(WHiMS) 
[29]  
Illness 
Perception 
Questionnai
re and a 
Menopause 
Specific 
Quality of 
Life 
How bothered 
on a 4 point 
scale in the 
last 6 months  
Headaches Aches In 
back/neck 
Dizziness Fatigue/we
ariness 
Shortness 
of breath 
Abdominal pain Eye irritation; 
Heartburn;  
Weight 
gain/loss; 
Chest pain at 
effort; 
Women’s 
International 
Study of 
Health and 
Sexuality 
(WISHeS)[3]  
 
Menopause
‐Specific 
Quality of 
Life 
 
Whether they 
had 
experienced 
the symptom 
in the 
previous 
month on a 7 
points scale 
Aches in 
neck, 
head, or 
shoulders 
Aching in 
muscles 
and joints 
Feeling 
tired or 
worn out 
Flatulence or 
gas pain; 
Breast pain or 
tenderness; 
Feeling 
bloated; Low 
backache; 
Decrease in 
physical 
strength; Lack 
of energy; 
Weight gain; 
Increased 
facial hair; 
Decrease in 
stamina; Dry 
skin; 
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Table 2:  Bivariate comparisons within cross-cultural studies of somatic symptoms. 
 AJMWHS 
[13] DAMeS [4] FMEG [25] 
HWHS 
[17] SWAN [18] WHiMNS [29] WISHES [3] 
 Ages  
45-60 
Current 
symptoms 
Ages 45-55 
Symptoms in past 
four weeks 
Ages 40-60 
Symptoms in past 6 
months 
Ages 40-60 
Symptoms 
in past two 
weeks 
Ages  40-55, 
Longitudinal 
Symptoms in past 
two weeks 
 Ages 45-64 
Bothersome 
symptoms in past 
6 months 
  
Ages 20-70 
Symptoms in past 
month. 
Prevalence at age 
50.
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=
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=
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=
2
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=
1
6
0
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=
1
2
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N
=
1
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1
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N
=
1
1
1
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N
=
2
0
3
 
J
a
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n
e
s
e
-
A
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N
=
2
4
9
 
A
f
r
c
a
n
 
A
m
 
N
=
4
1
6
3
 
H
i
s
p
-
a
n
i
c
 
N
=
1
8
5
9
 
C
h
i
n
e
s
e
 
N
=
6
2
5
 
J
a
p
a
n
e
s
e
 
N
=
8
1
1
 
J
e
w
i
s
h
 
 
N
=
5
4
0
 
S
o
v
i
e
t
 
i
m
m
i
g
r
a
n
t
 
N
=
1
5
1
 
A
r
a
b
 
I
s
r
a
e
l
i
s
 
N
=
1
2
3
 
U
S
 
,
 
U
K
 
 
 
 
U
S
 
n
=
2
0
5
0
,
 
E
u
r
.
 
n
=
2
4
6
7
 
F
r
a
n
c
e
,
 
I
t
a
l
y
 
G
e
r
m
a
n
y
 
Headaches 54 56 52 
* 
57 47 58 33 
** 
30 17 13 46 44 44 53 39 38 45
* 
53 58 40 40 40 
Aches/pain 78 
** 
72 44 
* 
54 56 54 63
** 
60 47 45 64 65 56 48 48 50 62 71 64 41b
+11 
41b
-7 
41b
-8 
Palpitations 35 
** 
42 47 
** 
34 29 29 27
** 
25 18 29             
Dizziness 25 
** 
42 38 
** 
37 25 24     14* 8     25 31 33    
Fatigue 
 
82 85 79 
** 
61 42 46 63
** 
58 58 32 51 
** 
37     33 
** 
41 12 44 
+8 
44 
-9 
44 
+1 
Breathing 
difficultiesc 
 
25 28 40 
** 
30 21 24 13
** 
13 4 13       11
* 
20 17    
Numbness or 
tingling 
36 39 51 
** 
28 40 22 37
** 
36 42 19             
Gastro-
intestinal pain 
(Abd pain) 
  38 
** 
17 27 24 29
** 
17 10 6       19 18 14 29 29 29 
a Numbers computed into yes/no frequencies from Anderson et al. [13]; significance is across 4 categories of not at all, a little, quite a bit, and extremely 
b Symptom prevalence at age 50 +/- the estimated increase or decrease in symptom prevalence due to country effect (Dennerstein et al. 2007) 
* significant p<0.05 ** significant p<0.01 
